Sanofi and GlaxoSmithKline are hoping to launch their latest Covid vaccine later this year after trials found it to be particularly effective against the omicron variant, promising news for the pharmaceutical giants as they push to make up lost ground and capture part of the maturing coronavirus vaccine market.
Read the source article at forbes.com
2022-06-24 01:00:00
